-
Examples of ableism I’ve encountered in life with FSHD
I’ve been disabled for over 50 years, and I spent over 30 years working with […]
-
Positive Interim Data from Wave Life Sciences Exon 53 Skipping Program
CureDuchenne is pleased to communicate that Wave Life Sciences announced positive interim data from the […]
-
Thanks to You PPMD Continues Forward in All Areas of Support
As we celebrate PPMD’s Duchenne Action Month inspired by World Duchenne Awareness Day, we are […]
-
Capricor will file this year for FDA approval of Deramiocel for the treatment of Duchenne cardiomyopathy
As an early investor in Capricor Therapeutics, CureDuchenne is happy to share that Capricor has […]
-
Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Individuals With Duchenne Amenable to Exon 53 Skipping
Wave Life Sciences has announced positive interim data from the ongoing Phase 2 FORWARD-53 study […]
-
Capricor Therapeutics Plans to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Cardiomyopathy
Capricor Therapeutics announced today its intent to file a Biologics License Application (BLA) seeking full […]
-
How I fully embrace life with limb-girdle muscular dystrophy
I believe that all of us who live with a chronic illness deal with a […]
-
Going gray prompts questions about the impact of caregiving on my life
I’m going gray. Wait, I should clarify that I’ve been coloring my hair since I […]
-
DMD treatment SMT-M01 gets FDA orphan drug, rare disease tags
SMT-M01, a Duchenne muscular dystrophy (DMD) treatment, was granted orphan drug and rare pediatric disease […]
-
PPMD Contributes to National Academies Report on Rare Disease Regulatory Processes
We are proud to highlight the National Academies of Sciences, Engineering, and Medicine (NASEM) Consensus […]
